Abstract
Quantification of hepatic fat and iron content is important for early detection and monitoring of nonalcoholic fatty liver disease (NAFLD) patients. This study evaluated quantification efficiency of hepatic proton density fat fraction (PDFF) by MRI using NAFLD rabbits. R2* was also measured to investigate whether it correlates with fat levels in NAFLD. NAFLD rabbit model was successfully established by high fat and cholesterol diet. Rabbits underwent MRI examination for fat and iron analyses, compared with liver histological findings. MR examinations were performed on a 3.0T MR system using multi-echo 3D gradient recalled echo (GRE) sequence. MRI-PDFF showed significant differences between different steatosis grades with medians of 3.72% (normal), 5.43% (mild), 9.11% (moderate) and 11.17% (severe), whereas this was not observed in R2*. Close correlation between MRI-PDFF and histological steatosis was observed (r=0.78, P=0.000). Hepatic iron deposit was not found in any rabbits. There was no correlation between R2* and either liver MRI-PDFF or histological steatosis. MR measuring MRI-PDFF and R2* simultaneously provides promising quantification of steatosis and iron. Rabbit NAFLD model confirmed accuracy of MRI-PDFF for liver fat quantification. R2* measurement and relationship between fat and iron of NAFLD liver need further experimental investigation.
Similar content being viewed by others
References
Artz, N.S., Haufe, W.M., Hooker, C.A., Hamilton, G., Wolfson, T., Campos, G.M., Gamst, A.C., Schwimmer, J.B., Sirlin, C.B., and Reeder, S. B. (2015). Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects. J Magn Reson Imag 42, 811–817
Bannas, P., Kramer, H., Hernando, D., Agni, R., Cunningham, A.M., Mandal, R., Motosugi, U., Sharma, S.D., Munoz del Rio, A., Fernandez, L., et al. (2015). Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 62, 1444–1455
Britton, L.J., Subramaniam, V.N., and Crawford, D.H. (2016). Iron and non-alcoholic fatty liver disease. World J Gastroenterol 22, 8112–8122
Bugianesi, E., Manzini, P., D’Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., and Rizzetto, M. (2004). Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39, 179–187
Goceri, E., Shah, Z.K., Layman, R., Jiang, X., and Gurcan, M.N. (2016). Quantification of liver fat: a comprehensive review. Comput Biol Med 71, 174–189
Hankins, J.S., McCarville, M.B., Loeffler, R.B., Smeltzer, M.P., Onciu, M., Hoffer, F.A., Li, C.S., Wang, W.C., Ware, R.E., and Hillenbrand, C.M. (2009). R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 113, 4853–4855
Hebbard, L. and George, J. (2011). Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 8, 35–44
Idilman, I.S., Aniktar, H., Idilman, R., Kabacam, G., Savas, B., Elhan, A., Celik, A., Bahar, K., and Karcaaltincaba, M. (2013). Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267, 767–775
Idilman, I.S., Tuzun, A., Savas, B., Elhan, A.H., Celik, A., Idilman, R., and Karcaaltincaba, M. (2015). Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imag 40, 1512–1519
Idilman, I.S., Keskin, O., Celik, A., Savas, B., Halil Elhan, A., Idilman, R., and Karcaaltincaba, M. (2016). A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol 57, 271–278
Joo, I., Lee, J.M., Yoon, J.H., Jang, J.J., Han, J.K., and Choi, B.I. (2014). Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging—an experimental study in a rabbit model. Radiology 270, 131–140
Karcaaltincaba, M., Idilman, I., and Celik, A. (2011). Focal sparing of iron and fat in liver tissue in patients with hemosiderosis: diagnosis with combination of R2* relaxometry and proton density fat fraction calculation by MRI. Diagnost Intervent Radiol 17, 323–327
Kato, A., Shinohara, Y., Yamashita, E., Fujii, S., Miyoshi, F., Kuya, K., and Ogawa, T. (2015). Usefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection. Neuroradiology 57, 909–915
Kukuk, G.M., Hittatiya, K., Sprinkart, A.M., Eggers, H., Gieseke, J., Block, W., Moeller, P., Willinek, W.A., Spengler, U., Trebicka, J., et al. (2015). Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol 25, 2869–2879
Liau, J., Shiehmorteza, M., Girard, O.M., Sirlin, C.B., and Bydder, M. (2013). Evaluation of MRI fat fraction in the liver and spine pre and post SPIO infusion. Magn Reson Imag 31, 1012–1016
Lin, S.C., Heba, E., Wolfson, T., Ang, B., Gamst, A., Han, A., Erdman Jr., J.W., O’Brien Jr., W.D., Andre, M.P., Sirlin, C.B., et al. (2015). Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin Gastroenterol Hepatol 13, 1337–1345.e6
Makovicky, P., Tumova, E., Volek, Z., and Sedlacek, R. (2016). Relationships between variable time, percentage of food restriction and liver histology: which alternative is the best for non-alcoholic fatty liver disease (NAFLD) prevention? Histol Histopathol 31, 1123–1130
Nelson, J.E., Wilson, L., Brunt, E.M., Yeh, M.M., Kleiner, D.E., Unalp-Arida, A., Kowdley, K.V., and Kowdley, K.V. (2011). Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 53, 448–457
Park, S.H., Kim, P.N., Kim, K.W., Lee, S.W., Yoon, S.E., Park, S.W., Ha, H.K., Lee, M.G., Hwang, S., Lee, S.G., et al. (2006). Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239, 105–112
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., and Poynard, T. (2005). Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898–1906
Reeder, S.B., Robson, P.M., Yu, H., Shimakawa, A., Hines, C.D.G., Mc-Kenzie, C.A., and Brittain, J.H. (2009). Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imag 29, 1332–1339
Rinella, M.E. (2015). Nonalcoholic fatty liver disease. JAMA 313, 2263–2273
Runge, J.H., Bakker, P.J., Gaemers, I.C., Verheij, J., Hakvoort, T.B.M., Ottenhoff, R., Nederveen, A.J., and Stoker, J. (2014). Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology. Magn Reson Mater Phy 27, 317–327
Sharma, P., Altbach, M., Galons, J.P., Kalb, B., and Martin, D.R. (2014). Measurement of liver fat fraction and iron with MRI and MR spectroscopy techniques. Diagnost Intervent Radiol 20, 17–26
Su, Q., Bi, S., and Yang, X. (2017). Prioritization of liver MRI for distinguishing focal lesions. Sci China Life Sci 60, 28–36
Sun, T., Lin, X, and Chen, K (2014). Evaluation of hepatic steatosis using dual-energy CT with MR comparison. Front Biosci 19, 1377–1385
Tang, A., Desai, A., Hamilton, G., Wolfson, T., Gamst, A., Lam, J., Clark, L., Hooker, J., Chavez, T., Ang, B.D., et al. (2014). Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274, 416–425
Wang, X., and Zhou, X.J. (2017). Magnetic resonance imaging in personalized medicine. Sci China Life Sci 60, 1–4
Westphalen, A.C.A., Qayyum, A., Yeh, B.M., Merriman, R.B., Lee, J.A., Lamba, A., Lu, Y., and Coakley, F.V. (2007). Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242, 450–455
Yamada, T., Obata, A., Kashiwagi, Y., Rokugawa, T., Matsushima, S., Hamada, T., Watabe, H., and Abe, K. (2016). Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. Magn Reson Imag 34, 724–729
Yang, D., Zhang, J., Han, D., Jin, E., and Yang, Z. (2017). The role of apparent diffusion coefficient values in characterization of solid focal liver lesions: a prospective and comparative clinical study. Sci China Life Sci 60, 16–22
Yoon, J.H., Lee, J.M., Suh, K.S., Lee, K.W., Yi., N.J., Lee, K.B., Han, J.K., and Choi, B.I. (2015). Combined use of MR fat quantification and MR elastography in living liver donors: can it reduce the need for preoperative liver biopsy? Radiology 276, 453–464
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, X., Zhang, X., Ma, L. et al. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease. Sci. China Life Sci. 61, 1107–1114 (2018). https://doi.org/10.1007/s11427-017-9279-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9279-1